Quoin Pharmaceuticals (QNRX) Total Liabilities (2017 - 2026)
Quoin Pharmaceuticals (QNRX) posted Total Liabilities of $6.9 million for Q1 2026, down 4.83% sequentially from $7.3 million in Q4 2025, and down 1.56% YoY from $7.0 million in Q1 2025.
Quoin Pharmaceuticals (QNRX) Total Liabilities (2017 - 2026) Analysis & Trends
Quoin Pharmaceuticals has reported Total Liabilities for 10 years, with the latest figure at $6.9 million in Q1 2026.
- Quarterly Total Liabilities fell 1.56% year-over-year to $6.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.9 million (down 1.56% YoY) and the FY2025 annual result came in at $7.3 million, up 11.78% from the prior year.
- Total Liabilities retreated to $6.9 million in Q1 2026 per QNRX's latest filing, from $7.3 million in the prior quarter.
- Over five years, Total Liabilities peaked at $7.7 million in Q3 2023 and troughed at $5.9 million in Q3 2024.
- A 5-year average of $7.0 million and a median of $7.0 million in 2022 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Liabilities retreated 22.3% in 2024, then grew 28.43% in 2025.
- Over 5 years, Total Liabilities stood at $7.1 million in 2022, then dropped by 7.74% to $6.5 million in 2023, then slipped by 0.01% to $6.5 million in 2024, then increased by 11.78% to $7.3 million in 2025, then slipped by 4.83% to $6.9 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $6.9 million, $7.3 million, and $7.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.20 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.35 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 10.03 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 3.22 Bn |
| 10 | Quoin Pharmaceuticals | 491,038.58 | 491,038.58 | - | 8.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.92 Mn |
| Dec 31, 2025 | 7.27 Mn |
| Sep 30, 2025 | 7.64 Mn |
| Jun 30, 2025 | 6.36 Mn |
| Mar 31, 2025 | 7.03 Mn |
| Dec 31, 2024 | 6.50 Mn |
| Sep 30, 2024 | 5.95 Mn |
| Jun 30, 2024 | 6.58 Mn |
| Mar 31, 2024 | 7.00 Mn |
| Dec 31, 2023 | 6.51 Mn |
| Sep 30, 2023 | 7.65 Mn |
| Jun 30, 2023 | 7.64 Mn |
| Mar 31, 2023 | 7.54 Mn |
| Dec 31, 2022 | 7.05 Mn |
| Sep 30, 2022 | 7.27 Mn |
| Jun 30, 2022 | 7.49 Mn |
| Dec 31, 2021 | 8.70 Mn |
| Dec 31, 2020 | 7.99 Mn |
| Jun 30, 2020 | 7.97 Mn |
| Jun 30, 2019 | 8.74 Mn |